NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

NCBiotech's Biomanufacturing and Process Development Exchange Group of industry professionals gathered for a symposium and vendor show earlier in April to confront the challenges of making cell and gene therapies.
A Research Triangle Park company that sells tools for cell studies is celebrating new funding to accelerate its selling.
Precision BioSciences, a genome-editing company based in Durham, announced today the opening of its highly prized production facility for in-house manufacturing of its unique technologies.
bluebird bio, a Massachusetts-based gene and cell therapy company, has opened its first wholly owned manufacturing facility in Durham amid cheers from state leaders.
Asklepios BioPharmaceutical, (AskBio), a Research Triangle Park platform company playing a key role in North Carolina’s global gene therapy leadership, got a $235 million vote of confidence today.
scroll back to top of page